These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 9160956)
1. Neuropeptides and Alzheimer's disease pathology. Bissette G Ann N Y Acad Sci; 1997 Apr; 814():17-29. PubMed ID: 9160956 [No Abstract] [Full Text] [Related]
3. CRH defects in Alzheimer's and other neurologic diseases. de Souza EB Hosp Pract (Off Ed); 1988 Sep; 23(9):59-71. PubMed ID: 2901426 [No Abstract] [Full Text] [Related]
4. The preeminent role of neuropeptide systems in the early pathophysiology of Alzheimer disease: up with corticotropin-releasing factor, down with acetylcholine. Nemeroff CB Arch Gen Psychiatry; 1999 Nov; 56(11):991-2. PubMed ID: 10565497 [No Abstract] [Full Text] [Related]
5. Neuronal communication breakdown in neurotransmitter systems in Alzheimer's and Parkinson's dementias. Chan-Palay V J Neurocytol; 1990 Oct; 19(5):802-6. PubMed ID: 1706418 [No Abstract] [Full Text] [Related]
6. Somatostatin and GHRH: mood and behavioral regulation. Rubinow DR; Post RM; Davis CL; Doran AR Adv Biochem Psychopharmacol; 1987; 43():137-52. PubMed ID: 2884816 [No Abstract] [Full Text] [Related]
7. [Neuromediators and memory. From research to therapy]. Zuber M; Guez D Ann Med Interne (Paris); 1989; 140(8):709-14. PubMed ID: 2576500 [No Abstract] [Full Text] [Related]
9. Recent advances in the neurochemical pathology of Alzheimer's disease. Studies of neuropeptides, cholinergic function and Alzheimer's disease-associated protein. Nemeroff CB; Bissette G; Slotkin TA; Seidler FJ; Miller BE; Ghanbari H Ann N Y Acad Sci; 1991; 640():193-6. PubMed ID: 1685644 [TBL] [Abstract][Full Text] [Related]
10. Neuropeptidergic systems in plaques of Alzheimer's disease. Struble RG; Powers RE; Casanova MF; Kitt CA; Brown EC; Price DL J Neuropathol Exp Neurol; 1987 Sep; 46(5):567-84. PubMed ID: 2442313 [TBL] [Abstract][Full Text] [Related]
11. Neuropeptide abnormalities in patients with early Alzheimer disease. Davis KL; Mohs RC; Marin DB; Purohit DP; Perl DP; Lantz M; Austin G; Haroutunian V Arch Gen Psychiatry; 1999 Nov; 56(11):981-7. PubMed ID: 10565496 [TBL] [Abstract][Full Text] [Related]
13. Neuropeptides and the autonomic nervous system. Fisher LA; Brown MR Psychother Psychosom; 1993; 60(1):39-45. PubMed ID: 7901867 [TBL] [Abstract][Full Text] [Related]
14. [Neuropeptides in Alzheimer's disease]. Jiménez-Corral C; Morán-Sánchez JC; Alonso-Navarro H Rev Neurol; 2006 Mar 16-31; 42(6):354-9. PubMed ID: 16575772 [TBL] [Abstract][Full Text] [Related]
15. Neuropeptide regulation of autonomic outflow at the sympathetic preganglionic neuron. Anatomical and neurochemical specificity. Krukoff TL Ann N Y Acad Sci; 1990; 579():160-7. PubMed ID: 1692453 [No Abstract] [Full Text] [Related]
16. Brain peptides as intercellular messengers. Implications for medicine. Brown MR; Fisher LA JAMA; 1984 Mar; 251(10):1310-5. PubMed ID: 6142126 [No Abstract] [Full Text] [Related]
17. Alzheimer's disease and aluminum toxicology. Corain B; Bombi GG; Tapparo A; Nicolini M; Zatta P; Perazzolo M; Favarato M Environ Health Perspect; 1990 Nov; 89():233-5. PubMed ID: 1982433 [No Abstract] [Full Text] [Related]
19. Peptides in the neocortex in Alzheimer's disease and ageing. Ferrier IN; Leake A Psychoneuroendocrinology; 1990; 15(2):89-95. PubMed ID: 1972799 [TBL] [Abstract][Full Text] [Related]
20. Coexistence of neuropeptides and "classical" neurotransmitters. Functional interactions between galanin and acetylcholine. Crawley JN Ann N Y Acad Sci; 1990; 579():233-45. PubMed ID: 1692455 [No Abstract] [Full Text] [Related] [Next] [New Search]